Successful Treatment and Secondary Prevention of Venous Thrombosis Secondary to Behçet Disease with Rivaroxaban
We here present the successful initial treatment and secondary prophylaxis of superficial venous thrombosis secondary to Behçet’s disease by a novel anticoagulant drug, rivaroxaban (Xarelto®). To our knowledge, this is the first case of using an oral direct inhibitor of FXa in this setting. Our find...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Case Reports in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2016/2164329 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832562811182514176 |
|---|---|
| author | Ana Boban Catherine Lambert Cedric Hermans |
| author_facet | Ana Boban Catherine Lambert Cedric Hermans |
| author_sort | Ana Boban |
| collection | DOAJ |
| description | We here present the successful initial treatment and secondary prophylaxis of superficial venous thrombosis secondary to Behçet’s disease by a novel anticoagulant drug, rivaroxaban (Xarelto®). To our knowledge, this is the first case of using an oral direct inhibitor of FXa in this setting. Our findings are promising; the outcome was favourable without any adverse effect noted. We propose that the patients with Behçet’s disease and venous thrombosis might benefit from the advantages of the new anticoagulant drug. |
| format | Article |
| id | doaj-art-6218c858c3cd4979a0a5274d59459003 |
| institution | Kabale University |
| issn | 2090-6560 2090-6579 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Hematology |
| spelling | doaj-art-6218c858c3cd4979a0a5274d594590032025-02-03T01:21:39ZengWileyCase Reports in Hematology2090-65602090-65792016-01-01201610.1155/2016/21643292164329Successful Treatment and Secondary Prevention of Venous Thrombosis Secondary to Behçet Disease with RivaroxabanAna Boban0Catherine Lambert1Cedric Hermans2Haemostasis and Thrombosis Unit, Division of Haematology, Haemophilia Clinic, Saint-Luc University Hospital, Avenue Hippocrate 10, 1200 Brussels, BelgiumHaemostasis and Thrombosis Unit, Division of Haematology, Haemophilia Clinic, Saint-Luc University Hospital, Avenue Hippocrate 10, 1200 Brussels, BelgiumHaemostasis and Thrombosis Unit, Division of Haematology, Haemophilia Clinic, Saint-Luc University Hospital, Avenue Hippocrate 10, 1200 Brussels, BelgiumWe here present the successful initial treatment and secondary prophylaxis of superficial venous thrombosis secondary to Behçet’s disease by a novel anticoagulant drug, rivaroxaban (Xarelto®). To our knowledge, this is the first case of using an oral direct inhibitor of FXa in this setting. Our findings are promising; the outcome was favourable without any adverse effect noted. We propose that the patients with Behçet’s disease and venous thrombosis might benefit from the advantages of the new anticoagulant drug.http://dx.doi.org/10.1155/2016/2164329 |
| spellingShingle | Ana Boban Catherine Lambert Cedric Hermans Successful Treatment and Secondary Prevention of Venous Thrombosis Secondary to Behçet Disease with Rivaroxaban Case Reports in Hematology |
| title | Successful Treatment and Secondary Prevention of Venous Thrombosis Secondary to Behçet Disease with Rivaroxaban |
| title_full | Successful Treatment and Secondary Prevention of Venous Thrombosis Secondary to Behçet Disease with Rivaroxaban |
| title_fullStr | Successful Treatment and Secondary Prevention of Venous Thrombosis Secondary to Behçet Disease with Rivaroxaban |
| title_full_unstemmed | Successful Treatment and Secondary Prevention of Venous Thrombosis Secondary to Behçet Disease with Rivaroxaban |
| title_short | Successful Treatment and Secondary Prevention of Venous Thrombosis Secondary to Behçet Disease with Rivaroxaban |
| title_sort | successful treatment and secondary prevention of venous thrombosis secondary to behcet disease with rivaroxaban |
| url | http://dx.doi.org/10.1155/2016/2164329 |
| work_keys_str_mv | AT anaboban successfultreatmentandsecondarypreventionofvenousthrombosissecondarytobehcetdiseasewithrivaroxaban AT catherinelambert successfultreatmentandsecondarypreventionofvenousthrombosissecondarytobehcetdiseasewithrivaroxaban AT cedrichermans successfultreatmentandsecondarypreventionofvenousthrombosissecondarytobehcetdiseasewithrivaroxaban |